explore -WSS

explore

author：explore 2025-10-01 02:12:05 - browse：9116

foreign-trained health professionals — Adobe

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.

The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.” The American Medical Association had no comment and deferred to other physician trade groups. The Federation of American Hospitals offered no statement.

The American Health Care Association, which lobbies on behalf of nursing homes, did not comment on the list of 10 drugs or Medicare’s negotiating power. But it said in a statement that “many nursing home residents have multiple chronic conditions that require several medications, so any efforts at reducing their out-of-pocket costs would be welcome.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： HHS secretary Becerra pressed on Change HealthCare cyberattack

WSS

HHS secretary Becerra pressed on Change HealthCare cyberattack

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

Male and female sex labels in research insufficient, scientists say

John Green on his newest strategy for fighting tuberculosis

5 wounded, 2 critically, in Michigan shopping center shooting

Snowpack in the West is melting rapidly. Where will all that extra water go?

Wikipedia

explore

Wikipedia

Medicare details structure of new drug price negotiation program

HHS secretary Becerra pressed on Change HealthCare cyberattack

Jerome Adams on the need for new antivirals for Covid

Poland's lawmakers approve a divisive law on Russian influence

DIEP, the 'gold standard' of breast reconstruction, is under threat

Many immigrants are left out of maternal health programs

After affirmative action ruling, medical educators look to 'holistic review'

EPA limits use of carcinogenic gas for sterilizing medical devices

In Memoriam: Notable people who died in 2023

Ebola: Gilead Sciences antiviral shows promise as new treatment

hotspot

RaDonda Vaught links Vanderbilt hospital issues to patient death

President Biden's budget: Here's what you might have missed

FDA advisers back CAR

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Ebola: Gilead Sciences antiviral shows promise as new treatment

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

focus

hotspot

Wikipedia

leisure time